DTL Is a Prognostic Biomarker and Promotes Bladder Cancer Progression through Regulating the AKT/mTOR axis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
DTL Is a Prognostic Biomarker and Promotes Bladder Cancer Progression through Regulating the AKT/mTOR axis
Authors
Keywords
-
Journal
Oxidative Medicine and Cellular Longevity
Volume 2022, Issue -, Pages 1-22
Publisher
Hindawi Limited
Online
2022-01-22
DOI
10.1155/2022/3369858
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR-198 inhibits the progression of renal cell carcinoma by targeting BIRC5
- (2021) Chao Yuan et al. Cancer Cell International
- Cancer cells dysregulate PI3K/AKT/mTOR pathway activation to ensure their survival and proliferation: mimicking them is a smart strategy of gammaherpesviruses
- (2021) Mara Cirone CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- CRL4Cdt2: Coupling Genome Stability to Ubiquitination
- (2020) Andreas Panagopoulos et al. TRENDS IN CELL BIOLOGY
- Targeting AKT/mTOR in Oral Cancer: Mechanisms and Advances in Clinical Trials
- (2020) Choudhary Harsha et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Bioinformatics Analysis of Prognostic miRNA Signature and Potential Critical Genes in Colon Cancer
- (2020) Weigang Chen et al. Frontiers in Genetics
- Tumor promoting effects of circRNA_001287 on renal cell carcinoma through miR-144-targeted CEP55
- (2020) Jiafu Feng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Identification of several cell cycle relevant genes highly correlated with the progression and prognosis of human bladder urothelial tumor
- (2019) Lu Wang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- MAPK4 overexpression promotes tumor progression via noncanonical activation of AKT/mTOR signaling
- (2019) Wei Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- CD47-targeted Near-Infrared Photoimmunotherapy for Human Bladder Cancer
- (2019) Bernahrd Kiss et al. CLINICAL CANCER RESEARCH
- UHRF1 promotes renal cell carcinoma progression through epigenetic regulation of TXNIP
- (2019) Dian Jiao et al. ONCOGENE
- Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer: Biological and therapeutic significance
- (2019) Meran Keshawa Ediriweera et al. SEMINARS IN CANCER BIOLOGY
- RNA sequencing: the teenage years
- (2019) Rory Stark et al. NATURE REVIEWS GENETICS
- Identification of 9 key genes and small molecule drugs in clear cell renal cell carcinoma
- (2019) Yongwen Luo et al. Aging-US
- Identification of a functional polymorphism within the 3′-untranslated region of denticleless E3 ubiquitin protein ligase homolog associated with survival in acral melanoma
- (2019) Lu Yang et al. EUROPEAN JOURNAL OF CANCER
- DTL promotes cancer progression by PDCD4 ubiquitin-dependent degradation
- (2019) Haoran Cui et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis
- (2019) Zengyuan Zhou et al. CELL TRANSPLANTATION
- SPAG5 promotes proliferation and suppresses apoptosis in bladder urothelial carcinoma by upregulating Wnt3 via activating the AKT/mTOR pathway and predicts poorer survival
- (2018) J. Y. Liu et al. ONCOGENE
- Non-muscle-invasive bladder cancer: a vision for the future
- (2017) Per-Uno Malmström et al. Scandinavian Journal of Urology
- Metabolic phenotype of bladder cancer
- (2016) Francesco Massari et al. CANCER TREATMENT REVIEWS
- Inactivation of the CRL4-CDT2-SET8/p21 ubiquitylation and degradation axis underlies the therapeutic efficacy of pevonedistat in melanoma
- (2016) Mouadh Benamar et al. EBioMedicine
- Emerging therapeutic targets in bladder cancer
- (2015) Benedito A. Carneiro et al. CANCER TREATMENT REVIEWS
- Overexpression of denticleless E3 ubiquitin protein ligase homolog (DTL) is related to poor outcome in gastric carcinoma
- (2015) Hiroki Kobayashi et al. Oncotarget
- Ubiquitin E3 Ligase CRL4CDT2/DCAF2as a Potential Chemotherapeutic Target for Ovarian Surface Epithelial Cancer
- (2013) Wei-Wei Pan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
- (2012) Guangchuang Yu et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- The Cul4-Ddb1Cdt2 Ubiquitin Ligase Inhibits Invasion of a Boundary-Associated Antisilencing Factor into Heterochromatin
- (2011) Sigurd Braun et al. CELL
- New Strategies in Muscle-Invasive Bladder Cancer: On the Road to Personalized Medicine
- (2011) J. B. Shah et al. CLINICAL CANCER RESEARCH
- Control of Drosophila endocycles by E2F and CRL4CDT2
- (2011) Norman Zielke et al. NATURE
- CRL4Cdt2-Mediated Destruction of the Histone Methyltransferase Set8 Prevents Premature Chromatin Compaction in S Phase
- (2010) Richard C. Centore et al. MOLECULAR CELL
- CRL4Cdt2 Regulates Cell Proliferation and Histone Gene Expression by Targeting PR-Set7/Set8 for Degradation
- (2010) Tarek Abbas et al. MOLECULAR CELL
- Identification of retinoic acid-regulated nuclear matrix-associated protein as a novel regulator of gastric cancer
- (2009) J Li et al. BRITISH JOURNAL OF CANCER
- WGCNA: an R package for weighted correlation network analysis
- (2008) Peter Langfelder et al. BMC BIOINFORMATICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search